CNS Pharmaceuticals Inc Defensive Interval Ratio
CNS Pharmaceuticals Inc defensive interval ratio. CNS Pharmaceuticals Inc (CNSP) has a Defensive Interval Ratio of 0 days as of December 2025. Defensive assets of $0.00 (cash $-, short-term investments $-, receivables $0.00) cover 0 days of daily cash needs of $11.24K/day. See CNS Pharmaceuticals Inc short-term liquidity ratio to evaluate short-term liquidity relative to the company's equity base.
Defensive Interval Ratio
Defensive Assets
Daily Cash Need
Current Liabilities
Defensive Interval Ratio of CNS Pharmaceuticals Inc (2023–2025)
Defensive interval ratio of CNS Pharmaceuticals Inc from 2023 to 2025. This chart shows how CNS Pharmaceuticals Inc's Defensive Interval Ratio has evolved across 3 annual periods from 2023 to 2025. As of December 2025, the ratio stands at 0 days, meaning defensive assets of $0.00 can fund 0 days of operations without new revenue. Read CNS Pharmaceuticals Inc balance sheet liabilities for a breakdown of total debt and financial obligations.
CNS Pharmaceuticals Inc Defensive Interval Ratio by Year (2023–2025)
CNS Pharmaceuticals Inc defensive interval ratio by year from 2023 to 2025. The table below presents the year-by-year Defensive Interval Ratio for CNS Pharmaceuticals Inc from 2023 to 2025, covering 3 annual filings. Each row shows defensive assets, daily cash need, the DIR in days, and the change in days compared to the prior year. For the complete balance sheet picture, see total assets of CNS Pharmaceuticals Inc.
| Year | DIR (days) | Defensive Assets (USD) | Daily Cash Need | Cash | ST Investments | Change (days) |
|---|---|---|---|---|---|---|
| 2025 | 0 days | $0.00 | $11.24K/day | $- | $- | ▼ -128 days |
| 2024 | 128 days | $882.54K | $6.92K/day | $- | $- | ▲ +128 days |
| 2023 | 0 days | $0.00 | $16.80K/day | $- | $- | — |